Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unique Group is a Bangkok-headquartered private conglomerate with operations spanning gems and jewelry as well as healthcare. Its healthcare activities are conducted primarily through VE Healthcare Group, which focuses on pharmaceutical, nutraceutical, OTC product, and medical device marketing and distribution, along with branded products under Vexxa Lifesciences. The company appears to be commercially oriented rather than an R&D-stage biotech developer, with business concentrated in developing markets across Southeast Asia and parts of Asia/Africa. Vexxa Lifesciences develops, out-licenses manufacturing for, markets, and sells branded prescription pharmaceutical products, nutraceuticals, and OTC products. Overall, Unique Group should be viewed as a diversified commercial healthcare and trading group rather than a pure-play biotech or innovative pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unique Group.